Story perspectives

67% Maintain Depression Remission After Psilocybin Therapy

9/11/2025

33 7

Summary

Story summary

A study from The Ohio State University found that 67% of participants in psilocybin-assisted therapy for major depressive disorder remained in remission after five years, up from 58% at one year.
Participants reported improved mental health and a more manageable relationship with depression.
Many sought additional treatments post-trial, indicating a complex recovery process.
The study emphasizes the significance of therapeutic context in treatment success.
Limitations include a small sample size and absence of a control group, suggesting future research should involve larger, diverse groups.

1 of 1

Story summary

A study from The Ohio State University found that 67% of participants in psilocybin-assisted therapy for major depressive disorder remained in remission after five years, up from 58% at one year.
Participants reported improved mental health and a more manageable relationship with depression.
Many sought additional treatments post-trial, indicating a complex recovery process.
The study emphasizes the significance of therapeutic context in treatment success.
Limitations include a small sample size and absence of a control group, suggesting future research should involve larger, diverse groups.